Hospital Injectable Drugs Industry Research Report 2023
Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. In tablet form, some of the drugs become ineffective as they get dismantled in the stomach owing to the digestive enzymes. Generic injectables are pharmaceutical drugs that are bio-equivalent of a branded injectable in terms of dosage, strength, performance, intended use, side-effects and route of administration.
Highlights
The global Hospital Injectable Drugs market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In 2019, North America held the main share in global hospital injectable drugs market,with the propotion of 35%,Europe followed loosely ,at the propotion of 33%.
Hospira (Pfizer Inc.) occupied the biggest global hospital injectable drugs market share(13%), Fresenius Kabi followed closely at the propotion of 13%, Baxter and Sichuan Kelun Pharmaceutical also played a virtal role in the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hospital Injectable Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Injectable Drugs.
The Hospital Injectable Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hospital Injectable Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital Injectable Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Hospital Injectable Drugs type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Hospital Injectable Drugs are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Hospital Injectable Drugs segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Hospital Injectable Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Hospital Injectable Drugs market.
Hospital Injectable Drugs Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Hospital Injectable Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hospital Injectable Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Hospital Injectable Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Hospital Injectable Drugs industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hospital Injectable Drugs.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Hospital Injectable Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
Highlights
The global Hospital Injectable Drugs market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In 2019, North America held the main share in global hospital injectable drugs market,with the propotion of 35%,Europe followed loosely ,at the propotion of 33%.
Hospira (Pfizer Inc.) occupied the biggest global hospital injectable drugs market share(13%), Fresenius Kabi followed closely at the propotion of 13%, Baxter and Sichuan Kelun Pharmaceutical also played a virtal role in the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hospital Injectable Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Injectable Drugs.
The Hospital Injectable Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hospital Injectable Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital Injectable Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Hospira (Pfizer Inc.)
- Baxter
- Fresenius Kabi
- Sandoz (Novartis)
- Hikma Pharmaceuticals PLC
- Dr. Reddy’s Laboratories Ltd
- Grifols
- Nichi-Iko Group (Sagent)
- Teva Pharmaceutical
- Otsuka
- B.Braun
- JW Life Science
- Auromedics
- Sanofi
- Gland Pharma
- Endo International PLC
- Sichuan Kelun Pharmaceutical
- Cisen Pharmaceutical
- Shijiazhuang No. 4 Pharmaceutical
- Shandong Hualu Pharmaceutical
- CR Double-Crane
Global markets are presented by Hospital Injectable Drugs type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Hospital Injectable Drugs are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Hospital Injectable Drugs segment by Type
- Generic Sterile Injectables
- Sterile Intravenous (IV) Solutions
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Hospital Injectable Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Hospital Injectable Drugs market.
Hospital Injectable Drugs Segment by Application
- Oncology
- Anesthesia
- Anti-Infectives
- Parenteral Nutrition
- Cardiovascular Diseases
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Hospital Injectable Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hospital Injectable Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Hospital Injectable Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Hospital Injectable Drugs industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hospital Injectable Drugs.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Hospital Injectable Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
- What factors will challenge the Product Name market growth?
- Which end-use segment will expand at the fastest CAGR in the Product Name market?
- Which are the emerging players in the Product Name market?
- How concentrated is the Product Name market?
- Which factors are positively contributing to the Product Name market growth?
- Which are the novel product innovations in the Product Name market?
- Which product segment will emerge as the most lucrative in the Product Name market?
- Which factors are increasing the competition in the Product Name market?
- Which are the strategic measures taken by the Product Name industry players?
- Which region will witness inactive growth during the forecast period?
- What key trends are likely to emerge in the Product Name market in the coming years?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Hospital Injectable Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Hospital Injectable Drugs Revenue Market Share by Type (2018-2023)
Table 7. Global Hospital Injectable Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Hospital Injectable Drugs Revenue Market Share by Type (2024-2029)
Table 9. Global Hospital Injectable Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Hospital Injectable Drugs Revenue Market Share by Application (2018-2023)
Table 11. Global Hospital Injectable Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Hospital Injectable Drugs Revenue Market Share by Application (2024-2029)
Table 13. Global Hospital Injectable Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Hospital Injectable Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Hospital Injectable Drugs Market Share by Region (2018-2023)
Table 16. Global Hospital Injectable Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Hospital Injectable Drugs Market Share by Region (2024-2029)
Table 18. Hospital Injectable Drugs Market Trends
Table 19. Hospital Injectable Drugs Market Drivers
Table 20. Hospital Injectable Drugs Market Challenges
Table 21. Hospital Injectable Drugs Market Restraints
Table 22. Global Top Hospital Injectable Drugs Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Hospital Injectable Drugs Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Hospital Injectable Drugs Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Hospital Injectable Drugs, Headquarters and Area Served
Table 26. Global Hospital Injectable Drugs Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Hospital Injectable Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Hospital Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Hospital Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Hospital Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Hospital Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Hospital Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Hospital Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Hospital Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Hospital Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Hospital Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Hospital Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Hospital Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Hospital Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Hospital Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Hospital Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Hospital Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. Hospira (Pfizer Inc.) Company Detail
Table 46. Hospira (Pfizer Inc.) Business Overview
Table 47. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product
Table 48. Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 49. Hospira (Pfizer Inc.) Recent Development
Table 50. Baxter Company Detail
Table 51. Baxter Business Overview
Table 52. Baxter Hospital Injectable Drugs Product
Table 53. Baxter Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 54. Baxter Recent Development
Table 55. Fresenius Kabi Company Detail
Table 56. Fresenius Kabi Business Overview
Table 57. Fresenius Kabi Hospital Injectable Drugs Product
Table 58. Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 59. Fresenius Kabi Recent Development
Table 60. Sandoz (Novartis) Company Detail
Table 61. Sandoz (Novartis) Business Overview
Table 62. Sandoz (Novartis) Hospital Injectable Drugs Product
Table 63. Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 64. Sandoz (Novartis) Recent Development
Table 65. Hikma Pharmaceuticals PLC Company Detail
Table 66. Hikma Pharmaceuticals PLC Business Overview
Table 67. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product
Table 68. Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 69. Hikma Pharmaceuticals PLC Recent Development
Table 70. Dr. Reddy’s Laboratories Ltd Company Detail
Table 71. Dr. Reddy’s Laboratories Ltd Business Overview
Table 72. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product
Table 73. Dr. Reddy’s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 74. Dr. Reddy’s Laboratories Ltd Recent Development
Table 75. Grifols Company Detail
Table 76. Grifols Business Overview
Table 77. Grifols Hospital Injectable Drugs Product
Table 78. Grifols Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 79. Grifols Recent Development
Table 80. Nichi-Iko Group (Sagent) Company Detail
Table 81. Nichi-Iko Group (Sagent) Business Overview
Table 82. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product
Table 83. Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 84. Nichi-Iko Group (Sagent) Recent Development
Table 85. Teva Pharmaceutical Company Detail
Table 86. Teva Pharmaceutical Business Overview
Table 87. Teva Pharmaceutical Hospital Injectable Drugs Product
Table 88. Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 89. Teva Pharmaceutical Recent Development
Table 90. Otsuka Company Detail
Table 91. Otsuka Business Overview
Table 92. Otsuka Hospital Injectable Drugs Product
Table 93. Otsuka Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 94. Otsuka Recent Development
Table 95. B.Braun Company Detail
Table 96. B.Braun Business Overview
Table 97. B.Braun Hospital Injectable DrugsProduct
Table 98. B.Braun Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 99. B.Braun Recent Development
Table 100. JW Life Science Company Detail
Table 101. JW Life Science Business Overview
Table 102. JW Life Science Hospital Injectable DrugsProduct
Table 103. JW Life Science Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 104. JW Life Science Recent Development
Table 105. Auromedics Company Detail
Table 106. Auromedics Business Overview
Table 107. Auromedics Hospital Injectable DrugsProduct
Table 108. Auromedics Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 109. Auromedics Recent Development
Table 110. Sanofi Company Detail
Table 111. Sanofi Business Overview
Table 112. Sanofi Hospital Injectable DrugsProduct
Table 113. Sanofi Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 114. Sanofi Recent Development
Table 115. Gland Pharma Company Detail
Table 116. Gland Pharma Business Overview
Table 117. Gland Pharma Hospital Injectable DrugsProduct
Table 118. Gland Pharma Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 119. Gland Pharma Recent Development
Table 120. Endo International PLC Company Detail
Table 121. Endo International PLC Business Overview
Table 122. Endo International PLC Hospital Injectable DrugsProduct
Table 123. Endo International PLC Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 124. Endo International PLC Recent Development
Table 125. Sichuan Kelun Pharmaceutical Company Detail
Table 126. Sichuan Kelun Pharmaceutical Business Overview
Table 127. Sichuan Kelun Pharmaceutical Hospital Injectable DrugsProduct
Table 128. Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 129. Sichuan Kelun Pharmaceutical Recent Development
Table 130. Cisen Pharmaceutical Company Detail
Table 131. Cisen Pharmaceutical Business Overview
Table 132. Cisen Pharmaceutical Hospital Injectable DrugsProduct
Table 133. Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 134. Cisen Pharmaceutical Recent Development
Table 135. Shijiazhuang No. 4 Pharmaceutical Company Detail
Table 136. Shijiazhuang No. 4 Pharmaceutical Business Overview
Table 137. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable DrugsProduct
Table 138. Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 139. Shijiazhuang No. 4 Pharmaceutical Recent Development
Table 140. Shandong Hualu Pharmaceutical Company Detail
Table 141. Shandong Hualu Pharmaceutical Business Overview
Table 142. Shandong Hualu Pharmaceutical Hospital Injectable DrugsProduct
Table 143. Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 144. Shandong Hualu Pharmaceutical Recent Development
Table 145. CR Double-Crane Company Detail
Table 146. CR Double-Crane Business Overview
Table 147. CR Double-Crane Hospital Injectable DrugsProduct
Table 148. CR Double-Crane Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 149. CR Double-Crane Recent Development
Table 150. Hospira (Pfizer Inc.) Company Information
Table 151. Hospira (Pfizer Inc.) Business Overview
Table 152. Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 153. Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 154. Hospira (Pfizer Inc.) Recent Development
Table 155. Baxter Company Information
Table 156. Baxter Business Overview
Table 157. Baxter Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 158. Baxter Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 159. Baxter Recent Development
Table 160. Fresenius Kabi Company Information
Table 161. Fresenius Kabi Business Overview
Table 162. Fresenius Kabi Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 163. Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 164. Fresenius Kabi Recent Development
Table 165. Sandoz (Novartis) Company Information
Table 166. Sandoz (Novartis) Business Overview
Table 167. Sandoz (Novartis) Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 168. Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 169. Sandoz (Novartis) Recent Development
Table 170. Hikma Pharmaceuticals PLC Company Information
Table 171. Hikma Pharmaceuticals PLC Business Overview
Table 172. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 173. Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 174. Hikma Pharmaceuticals PLC Recent Development
Table 175. Dr. Reddy’s Laboratories Ltd Company Information
Table 176. Dr. Reddy’s Laboratories Ltd Business Overview
Table 177. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 178. Dr. Reddy’s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 179. Dr. Reddy’s Laboratories Ltd Recent Development
Table 180. Grifols Company Information
Table 181. Grifols Business Overview
Table 182. Grifols Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 183. Grifols Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 184. Grifols Recent Development
Table 185. Nichi-Iko Group (Sagent) Company Information
Table 186. Nichi-Iko Group (Sagent) Business Overview
Table 187. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 188. Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 189. Nichi-Iko Group (Sagent) Recent Development
Table 190. Teva Pharmaceutical Company Information
Table 191. Teva Pharmaceutical Business Overview
Table 192. Teva Pharmaceutical Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 193. Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 194. Teva Pharmaceutical Recent Development
Table 195. Otsuka Company Information
Table 196. Otsuka Business Overview
Table 197. Otsuka Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 198. Otsuka Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 199. Otsuka Recent Development
Table 200. B.Braun Company Information
Table 201. B.Braun Business Overview
Table 202. B.Braun Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 203. B.Braun Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 204. B.Braun Recent Development
Table 205. JW Life Science Company Information
Table 206. JW Life Science Business Overview
Table 207. JW Life Science Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 208. JW Life Science Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 209. JW Life Science Recent Development
Table 210. Auromedics Company Information
Table 211. Auromedics Business Overview
Table 212. Auromedics Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 213. Auromedics Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 214. Auromedics Recent Development
Table 215. Sanofi Company Information
Table 216. Sanofi Business Overview
Table 217. Sanofi Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 218. Sanofi Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 219. Sanofi Recent Development
Table 220. Gland Pharma Company Information
Table 221. Gland Pharma Business Overview
Table 222. Gland Pharma Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 223. Gland Pharma Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 224. Gland Pharma Recent Development
Table 225. Endo International PLC Company Information
Table 226. Endo International PLC Business Overview
Table 227. Endo International PLC Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 228. Endo International PLC Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 229. Endo International PLC Recent Development
Table 230. Sichuan Kelun Pharmaceutical Company Information
Table 231. Sichuan Kelun Pharmaceutical Business Overview
Table 232. Sichuan Kelun Pharmaceutical Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 233. Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 234. Sichuan Kelun Pharmaceutical Recent Development
Table 235. Cisen Pharmaceutical Company Information
Table 236. Cisen Pharmaceutical Business Overview
Table 237. Cisen Pharmaceutical Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 238. Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 239. Cisen Pharmaceutical Recent Development
Table 240. Shijiazhuang No. 4 Pharmaceutical Company Information
Table 241. Shijiazhuang No. 4 Pharmaceutical Business Overview
Table 242. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 243. Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 244. Shijiazhuang No. 4 Pharmaceutical Recent Development
Table 245. Shandong Hualu Pharmaceutical Company Information
Table 246. Shandong Hualu Pharmaceutical Business Overview
Table 247. Shandong Hualu Pharmaceutical Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 248. Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 249. Shandong Hualu Pharmaceutical Recent Development
Table 250. CR Double-Crane Company Information
Table 251. CR Double-Crane Business Overview
Table 252. CR Double-Crane Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 253. CR Double-Crane Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 254. CR Double-Crane Recent Development
Table 255. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Hospital Injectable Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Hospital Injectable Drugs Revenue Market Share by Type (2018-2023)
Table 7. Global Hospital Injectable Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Hospital Injectable Drugs Revenue Market Share by Type (2024-2029)
Table 9. Global Hospital Injectable Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Hospital Injectable Drugs Revenue Market Share by Application (2018-2023)
Table 11. Global Hospital Injectable Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Hospital Injectable Drugs Revenue Market Share by Application (2024-2029)
Table 13. Global Hospital Injectable Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Hospital Injectable Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Hospital Injectable Drugs Market Share by Region (2018-2023)
Table 16. Global Hospital Injectable Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Hospital Injectable Drugs Market Share by Region (2024-2029)
Table 18. Hospital Injectable Drugs Market Trends
Table 19. Hospital Injectable Drugs Market Drivers
Table 20. Hospital Injectable Drugs Market Challenges
Table 21. Hospital Injectable Drugs Market Restraints
Table 22. Global Top Hospital Injectable Drugs Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Hospital Injectable Drugs Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Hospital Injectable Drugs Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Hospital Injectable Drugs, Headquarters and Area Served
Table 26. Global Hospital Injectable Drugs Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Hospital Injectable Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Hospital Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Hospital Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Hospital Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Hospital Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Hospital Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Hospital Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Hospital Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Hospital Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Hospital Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Hospital Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Hospital Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Hospital Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Hospital Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Hospital Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Hospital Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. Hospira (Pfizer Inc.) Company Detail
Table 46. Hospira (Pfizer Inc.) Business Overview
Table 47. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product
Table 48. Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 49. Hospira (Pfizer Inc.) Recent Development
Table 50. Baxter Company Detail
Table 51. Baxter Business Overview
Table 52. Baxter Hospital Injectable Drugs Product
Table 53. Baxter Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 54. Baxter Recent Development
Table 55. Fresenius Kabi Company Detail
Table 56. Fresenius Kabi Business Overview
Table 57. Fresenius Kabi Hospital Injectable Drugs Product
Table 58. Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 59. Fresenius Kabi Recent Development
Table 60. Sandoz (Novartis) Company Detail
Table 61. Sandoz (Novartis) Business Overview
Table 62. Sandoz (Novartis) Hospital Injectable Drugs Product
Table 63. Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 64. Sandoz (Novartis) Recent Development
Table 65. Hikma Pharmaceuticals PLC Company Detail
Table 66. Hikma Pharmaceuticals PLC Business Overview
Table 67. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product
Table 68. Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 69. Hikma Pharmaceuticals PLC Recent Development
Table 70. Dr. Reddy’s Laboratories Ltd Company Detail
Table 71. Dr. Reddy’s Laboratories Ltd Business Overview
Table 72. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product
Table 73. Dr. Reddy’s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 74. Dr. Reddy’s Laboratories Ltd Recent Development
Table 75. Grifols Company Detail
Table 76. Grifols Business Overview
Table 77. Grifols Hospital Injectable Drugs Product
Table 78. Grifols Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 79. Grifols Recent Development
Table 80. Nichi-Iko Group (Sagent) Company Detail
Table 81. Nichi-Iko Group (Sagent) Business Overview
Table 82. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product
Table 83. Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 84. Nichi-Iko Group (Sagent) Recent Development
Table 85. Teva Pharmaceutical Company Detail
Table 86. Teva Pharmaceutical Business Overview
Table 87. Teva Pharmaceutical Hospital Injectable Drugs Product
Table 88. Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 89. Teva Pharmaceutical Recent Development
Table 90. Otsuka Company Detail
Table 91. Otsuka Business Overview
Table 92. Otsuka Hospital Injectable Drugs Product
Table 93. Otsuka Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 94. Otsuka Recent Development
Table 95. B.Braun Company Detail
Table 96. B.Braun Business Overview
Table 97. B.Braun Hospital Injectable DrugsProduct
Table 98. B.Braun Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 99. B.Braun Recent Development
Table 100. JW Life Science Company Detail
Table 101. JW Life Science Business Overview
Table 102. JW Life Science Hospital Injectable DrugsProduct
Table 103. JW Life Science Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 104. JW Life Science Recent Development
Table 105. Auromedics Company Detail
Table 106. Auromedics Business Overview
Table 107. Auromedics Hospital Injectable DrugsProduct
Table 108. Auromedics Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 109. Auromedics Recent Development
Table 110. Sanofi Company Detail
Table 111. Sanofi Business Overview
Table 112. Sanofi Hospital Injectable DrugsProduct
Table 113. Sanofi Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 114. Sanofi Recent Development
Table 115. Gland Pharma Company Detail
Table 116. Gland Pharma Business Overview
Table 117. Gland Pharma Hospital Injectable DrugsProduct
Table 118. Gland Pharma Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 119. Gland Pharma Recent Development
Table 120. Endo International PLC Company Detail
Table 121. Endo International PLC Business Overview
Table 122. Endo International PLC Hospital Injectable DrugsProduct
Table 123. Endo International PLC Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 124. Endo International PLC Recent Development
Table 125. Sichuan Kelun Pharmaceutical Company Detail
Table 126. Sichuan Kelun Pharmaceutical Business Overview
Table 127. Sichuan Kelun Pharmaceutical Hospital Injectable DrugsProduct
Table 128. Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 129. Sichuan Kelun Pharmaceutical Recent Development
Table 130. Cisen Pharmaceutical Company Detail
Table 131. Cisen Pharmaceutical Business Overview
Table 132. Cisen Pharmaceutical Hospital Injectable DrugsProduct
Table 133. Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 134. Cisen Pharmaceutical Recent Development
Table 135. Shijiazhuang No. 4 Pharmaceutical Company Detail
Table 136. Shijiazhuang No. 4 Pharmaceutical Business Overview
Table 137. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable DrugsProduct
Table 138. Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 139. Shijiazhuang No. 4 Pharmaceutical Recent Development
Table 140. Shandong Hualu Pharmaceutical Company Detail
Table 141. Shandong Hualu Pharmaceutical Business Overview
Table 142. Shandong Hualu Pharmaceutical Hospital Injectable DrugsProduct
Table 143. Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 144. Shandong Hualu Pharmaceutical Recent Development
Table 145. CR Double-Crane Company Detail
Table 146. CR Double-Crane Business Overview
Table 147. CR Double-Crane Hospital Injectable DrugsProduct
Table 148. CR Double-Crane Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 149. CR Double-Crane Recent Development
Table 150. Hospira (Pfizer Inc.) Company Information
Table 151. Hospira (Pfizer Inc.) Business Overview
Table 152. Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 153. Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 154. Hospira (Pfizer Inc.) Recent Development
Table 155. Baxter Company Information
Table 156. Baxter Business Overview
Table 157. Baxter Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 158. Baxter Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 159. Baxter Recent Development
Table 160. Fresenius Kabi Company Information
Table 161. Fresenius Kabi Business Overview
Table 162. Fresenius Kabi Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 163. Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 164. Fresenius Kabi Recent Development
Table 165. Sandoz (Novartis) Company Information
Table 166. Sandoz (Novartis) Business Overview
Table 167. Sandoz (Novartis) Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 168. Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 169. Sandoz (Novartis) Recent Development
Table 170. Hikma Pharmaceuticals PLC Company Information
Table 171. Hikma Pharmaceuticals PLC Business Overview
Table 172. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 173. Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 174. Hikma Pharmaceuticals PLC Recent Development
Table 175. Dr. Reddy’s Laboratories Ltd Company Information
Table 176. Dr. Reddy’s Laboratories Ltd Business Overview
Table 177. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 178. Dr. Reddy’s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 179. Dr. Reddy’s Laboratories Ltd Recent Development
Table 180. Grifols Company Information
Table 181. Grifols Business Overview
Table 182. Grifols Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 183. Grifols Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 184. Grifols Recent Development
Table 185. Nichi-Iko Group (Sagent) Company Information
Table 186. Nichi-Iko Group (Sagent) Business Overview
Table 187. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 188. Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 189. Nichi-Iko Group (Sagent) Recent Development
Table 190. Teva Pharmaceutical Company Information
Table 191. Teva Pharmaceutical Business Overview
Table 192. Teva Pharmaceutical Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 193. Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 194. Teva Pharmaceutical Recent Development
Table 195. Otsuka Company Information
Table 196. Otsuka Business Overview
Table 197. Otsuka Hospital Injectable Drugs Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 198. Otsuka Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 199. Otsuka Recent Development
Table 200. B.Braun Company Information
Table 201. B.Braun Business Overview
Table 202. B.Braun Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 203. B.Braun Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 204. B.Braun Recent Development
Table 205. JW Life Science Company Information
Table 206. JW Life Science Business Overview
Table 207. JW Life Science Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 208. JW Life Science Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 209. JW Life Science Recent Development
Table 210. Auromedics Company Information
Table 211. Auromedics Business Overview
Table 212. Auromedics Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 213. Auromedics Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 214. Auromedics Recent Development
Table 215. Sanofi Company Information
Table 216. Sanofi Business Overview
Table 217. Sanofi Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 218. Sanofi Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 219. Sanofi Recent Development
Table 220. Gland Pharma Company Information
Table 221. Gland Pharma Business Overview
Table 222. Gland Pharma Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 223. Gland Pharma Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 224. Gland Pharma Recent Development
Table 225. Endo International PLC Company Information
Table 226. Endo International PLC Business Overview
Table 227. Endo International PLC Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 228. Endo International PLC Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 229. Endo International PLC Recent Development
Table 230. Sichuan Kelun Pharmaceutical Company Information
Table 231. Sichuan Kelun Pharmaceutical Business Overview
Table 232. Sichuan Kelun Pharmaceutical Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 233. Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 234. Sichuan Kelun Pharmaceutical Recent Development
Table 235. Cisen Pharmaceutical Company Information
Table 236. Cisen Pharmaceutical Business Overview
Table 237. Cisen Pharmaceutical Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 238. Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 239. Cisen Pharmaceutical Recent Development
Table 240. Shijiazhuang No. 4 Pharmaceutical Company Information
Table 241. Shijiazhuang No. 4 Pharmaceutical Business Overview
Table 242. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 243. Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 244. Shijiazhuang No. 4 Pharmaceutical Recent Development
Table 245. Shandong Hualu Pharmaceutical Company Information
Table 246. Shandong Hualu Pharmaceutical Business Overview
Table 247. Shandong Hualu Pharmaceutical Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 248. Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 249. Shandong Hualu Pharmaceutical Recent Development
Table 250. CR Double-Crane Company Information
Table 251. CR Double-Crane Business Overview
Table 252. CR Double-Crane Hospital Injectable DrugsRevenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million)
Table 253. CR Double-Crane Revenue in Hospital Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 254. CR Double-Crane Recent Development
Table 255. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Hospital Injectable Drugs Product Picture
Figure 5. Global Hospital Injectable Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Hospital Injectable Drugs Market Share by Type: 2022 VS 2029
Figure 7. Generic Sterile Injectables Product Picture
Figure 8. Sterile Intravenous (IV) Solutions Product Picture
Figure 9. Global Hospital Injectable Drugs Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Hospital Injectable Drugs Market Share by Application: 2022 VS 2029
Figure 11. Oncology Product Picture
Figure 12. Anesthesia Product Picture
Figure 13. Anti-Infectives Product Picture
Figure 14. Parenteral Nutrition Product Picture
Figure 15. Cardiovascular Diseases Product Picture
Figure 16. Global Hospital Injectable Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Hospital Injectable Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Hospital Injectable Drugs Market Share by Region: 2022 VS 2029
Figure 19. Global Hospital Injectable Drugs Market Share by Players in 2022
Figure 20. Global Hospital Injectable Drugs Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Hospital Injectable Drugs Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Hospital Injectable Drugs Market Share by Country (2018-2029)
Figure 25. United States Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Hospital Injectable Drugs Market Share by Country (2018-2029)
Figure 29. Germany Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Hospital Injectable Drugs Market Share by Country (2018-2029)
Figure 37. China Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Hospital Injectable Drugs Market Share by Country (2018-2029)
Figure 45. Mexico Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Hospital Injectable Drugs Market Share by Country (2018-2029)
Figure 49. Turkey Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Hospira (Pfizer Inc.) Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 53. Baxter Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 54. Fresenius Kabi Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 55. Sandoz (Novartis) Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 56. Hikma Pharmaceuticals PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 57. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 58. Grifols Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 59. Nichi-Iko Group (Sagent) Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 60. Teva Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 61. Otsuka Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 62. B.Braun Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 63. JW Life Science Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 64. Auromedics Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 65. Sanofi Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 66. Gland Pharma Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 67. Endo International PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 68. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 69. Cisen Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 70. Shijiazhuang No. 4 Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 71. Shandong Hualu Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 72. CR Double-Crane Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Hospital Injectable Drugs Product Picture
Figure 5. Global Hospital Injectable Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Hospital Injectable Drugs Market Share by Type: 2022 VS 2029
Figure 7. Generic Sterile Injectables Product Picture
Figure 8. Sterile Intravenous (IV) Solutions Product Picture
Figure 9. Global Hospital Injectable Drugs Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Hospital Injectable Drugs Market Share by Application: 2022 VS 2029
Figure 11. Oncology Product Picture
Figure 12. Anesthesia Product Picture
Figure 13. Anti-Infectives Product Picture
Figure 14. Parenteral Nutrition Product Picture
Figure 15. Cardiovascular Diseases Product Picture
Figure 16. Global Hospital Injectable Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Hospital Injectable Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Hospital Injectable Drugs Market Share by Region: 2022 VS 2029
Figure 19. Global Hospital Injectable Drugs Market Share by Players in 2022
Figure 20. Global Hospital Injectable Drugs Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Hospital Injectable Drugs Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Hospital Injectable Drugs Market Share by Country (2018-2029)
Figure 25. United States Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Hospital Injectable Drugs Market Share by Country (2018-2029)
Figure 29. Germany Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Hospital Injectable Drugs Market Share by Country (2018-2029)
Figure 37. China Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Hospital Injectable Drugs Market Share by Country (2018-2029)
Figure 45. Mexico Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Hospital Injectable Drugs Market Share by Country (2018-2029)
Figure 49. Turkey Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Hospital Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Hospira (Pfizer Inc.) Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 53. Baxter Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 54. Fresenius Kabi Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 55. Sandoz (Novartis) Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 56. Hikma Pharmaceuticals PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 57. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 58. Grifols Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 59. Nichi-Iko Group (Sagent) Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 60. Teva Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 61. Otsuka Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 62. B.Braun Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 63. JW Life Science Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 64. Auromedics Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 65. Sanofi Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 66. Gland Pharma Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 67. Endo International PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 68. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 69. Cisen Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 70. Shijiazhuang No. 4 Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 71. Shandong Hualu Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
Figure 72. CR Double-Crane Revenue Growth Rate in Hospital Injectable Drugs Business (2018-2023)
